Companion Genetics is the first NGS-based cancer tumor profiling provider for cats — plus custom and whole-genome sequencing when a targeted panel isn't enough. Reports are written to translate directly into a treatment plan.
A curated panel of oncogenes relevant to feline tumor biology, sequenced by targeted NGS for high-depth, high-confidence variant calls on tumor tissue or FNA samples.
Need a gene set outside our standard panel? We design custom targeted panels or run whole-exome sequencing for novel or suspected mutations.
For research collaborations or complex cases, whole-genome sequencing gives the deepest possible view of an individual animal's genome.
Every report is written for the exam room: what was found, what it means, and what it changes about the treatment plan — not a raw variant list.
Associated with increased tyrosine kinase activity in mast cell tumors. Consider tyrosine kinase inhibitor response monitoring; discuss with a veterinary oncologist.
Tell us about your practice and caseload, and we'll follow up with pricing, kit logistics, and turnaround times. Breeders and research partners welcome.